top of page

Beyond the Swim-Up: Innovations in Sperm Selection for ART

  • Writer: Eric Lacy, PhD
    Eric Lacy, PhD
  • Jul 31
  • 3 min read

Updated: Aug 26

Hand holding magnifying glass to sperm with analytics and details

Rethinking How We Choose the Sperm That Matter Most

In the world of assisted reproductive technologies (ART), much of the innovation and attention focuses on egg retrieval, hormone stimulation, and embryo development. But behind the scenes in the lab, an equally critical process often gets overlooked: sperm selection.


For decades, embryologists have relied on conventional methods like swim-up and density gradient centrifugation to isolate the “best” sperm—typically defined by motility and morphology. But motility alone doesn’t always reflect true sperm quality, especially at the molecular and genetic level.


Emerging technologies are redefining how we evaluate and select sperm for use in procedures like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). These innovations offer new hope for improving outcomes—especially in cases involving male factor infertility, which accounts for up to 50% of infertility cases globally.


New Frontiers in Sperm Selection

Here are three next-generation approaches gaining traction in the lab:


Microfluidic Sperm Sorting

Microfluidic devices use narrow, biologically inspired channels to isolate sperm based on motility and morphology—without centrifugation, which can cause cellular stress. By mimicking the natural path sperm take through the female reproductive tract, this method helps select sperm with lower DNA fragmentation and improved viability. Studies like this one have shown promising results for microfluidics in IVF/ICSI cycles.


Magnetic-Activated Cell Sorting (MACS)

MACS technology selectively removes apoptotic sperm using magnetic nanoparticles attached to Annexin V, a marker for cell death. When placed in a magnetic field, dying sperm are filtered out, leaving a healthier population. Research has shown that MACS may improve embryo development and reduce miscarriage rates in certain cases, particularly where high DNA fragmentation is present.


Zeta Potential and Hyaluronic Acid (HA) Binding

These methods assess functional and genetic maturity of sperm.

  • Zeta potential measures electrical surface charge, helping isolate sperm with intact DNA.

  • HA binding mimics the natural binding process between sperm and egg, selecting sperm with reduced chromatin damage and better fertilization potential.


AF by Aqua Fem: A New Layer of Optimization

In parallel with these physical and biochemical selection technologies, Aqua Fem is pioneering a novel approach with AF, a patented compound designed to directly enhance sperm motility and function. AF is being developed as an additive to sperm washing media used in IVF and IUI procedures. Early lab data indicate that AF may significantly improve the quality and performance of sperm selected for ART—particularly in cases where traditional methods yield marginal gains. By supporting sperm at a cellular level, AF has the potential to augment existing sperm selection methods, improve fertilization rates, and offer new hope to couples navigating male factor infertility.


Why It Matters for Fertility Outcomes

Most semen analyses still only measure basic parameters: volume, count, motility, and morphology. While these are helpful, they don't tell the full story.


More advanced diagnostics—like sperm DNA fragmentation testing, oxidative stress assessment, and apoptotic markers—can provide a clearer picture of male fertility, particularly in cases of:

  • Unexplained infertility

  • Advanced paternal age

  • Recurrent IVF or ICSI failure

  • Previous poor embryo development


In these scenarios, technologies like microfluidics, MACS and AF can enhance sperm selection by focusing not just on movement, but on molecular quality, which is increasingly linked to better fertilization, implantation, and pregnancy outcomes.


The Bigger Picture: Equity in Fertility Care

At Aqua Fem, we’re deeply committed to shifting how the field thinks about male reproductive health. For too long, male fertility has been under-investigated, underfunded, and misunderstood.


By supporting research and innovation in sperm biology—and advocating for deeper diagnostic tools and smarter lab techniques—we hope to contribute to a more balanced, science-driven approach to fertility care. Because when we improve how we select sperm, we’re not just improving lab processes—we’re improving futures.


 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
Charleston, South Carolina
United States
AquaFem_Wordmark_White.png

Copyright © 2025 Aqua Fem, LLC. All Rights Reserved.

  • LinkedIn

Stay updated by following us on

bottom of page